Suppression of tumor growth in human hepatocellular carcinoma by systemic delivery of SNALP-formulated siRNA for downregulation of HDAC2

被引：0
|
作者：
Lee, Yun-Han
Song, Ho-Taek
Judge, Adam
Andersen, Jesper
Ishikawa, Tsuyoshi
Avital, Itzhak
Durkin, Marian
Raggi, Chiara
Ton, Anita
Conner, Elizabeth
MacLachlan, Ian
Factor, Valentina
Thorgeirsson, Snorri
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] Yonsei Univ, Seoul 120749, South Korea
[3] Protiva Biotherapeut Inc, Burnaby, BC, Canada
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2857
引用
收藏
页数：1
相关论文
共 43 条
  • [21] Rap_GAP Domain of TSC2 Contributes to Tumor Suppression Through mTOR Signaling in Human Hepatocellular Carcinoma
    Cui, Mengying
    Jiang, Weibo
    Sheng, Jiyao
    Wu, Jiacheng
    Zhang, Xuewen
    DNA AND CELL BIOLOGY, 2022, 41 (02) : 215 - 224
  • [22] Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma
    Liu, Juan
    Zhang, Cen
    Lin, Meihua
    Zhu, Wei
    Liang, Yingjian
    Hong, Xuehui
    Zhao, Yuhan
    Young, Ken H.
    Hu, Wenwei
    Feng, Zhaohui
    ONCOTARGET, 2014, 5 (09) : 2635 - 2647
  • [23] miR-23c suppresses tumor growth of human hepatocellular carcinoma by attenuating ERBB2IP
    Zhang, Lei
    Wang, Yufeng
    Wang, Liang
    Yin, Guozhi
    Li, Weimin
    Xian, Yao
    Yang, Wei
    Liu, Qingguang
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 424 - 432
  • [24] Targeted Disruption of Nemo-Like Kinase Inhibits Tumor Cell Growth by Simultaneous Suppression of Cyclin D1 and CDK2 in Human Hepatocellular Carcinoma
    Jung, Kwang Hwa
    Kim, Jeong Kyu
    Noh, Ji Heon
    Fun, Jung Woo
    Bae, Hyun Jin
    Xie, Hong Jian
    Ahn, Young Min
    Park, Won Sang
    Lee, Jung Young
    Nam, Suk Woo
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 110 (03) : 687 - 696
  • [25] Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma
    Jung, Kwang Hwa
    Kim, Eong Kyu
    Noh, Ji Hein
    Eun, Jung Woo
    Bae, Hyun Jln
    Xie, Hong Jian
    Park, Wong Sang
    Lee, Jung Young
    Nam, Suk Woo
    CANCER RESEARCH, 2010, 70
  • [26] Mechanistic Study on Growth Suppression and Apoptosis Induction by Targeting Hepatoma-derived Growth Factor in Human Hepatocellular Carcinoma HepG2 Cells
    Tsang, Tsun Yee
    Tanga, Wan Yee
    Tsang, Wing Pui
    Co, Ngai Na
    Kong, Siu Kai
    Kwok, Tim Tak
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2009, 24 (3-4) : 253 - 262
  • [27] Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma
    Wang, Ning
    Feng, Yibin
    Tan, Hor-Yue
    Cheung, Fan
    Hong, Ming
    Lao, Lixing
    Nagamatsu, Tadashi
    JOURNAL OF ETHNOPHARMACOLOGY, 2015, 164 : 309 - 318
  • [28] Aberrant regulation of Nemo-like kinase and its disruption elicits regression of tumor cell growth by cyclin D1 and CDK2 suppression in human hepatocellular carcinoma
    Jung, Kwang Hwa
    Kim, Jeong Kyu
    Noh, Ji Heon
    Eun, Jung Woo
    Bae, Hyun Jin
    Xie, Hong Jian
    Park, Won Sang
    Lee, Jung Young
    Nam, Suk Woo
    MOLECULAR & CELLULAR TOXICOLOGY, 2009, 5 (03) : 48 - 48
  • [29] Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo
    Jang, Ji-Young
    Choi, Yun
    Jeon, Yoon-Kyung
    Kim, Chul-Woo
    BREAST CANCER RESEARCH, 2008, 10 (01):
  • [30] Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo
    Ji-Young Jang
    Yun Choi
    Yoon-Kyung Jeon
    Chul-Woo Kim
    Breast Cancer Research, 10
12345